LUCY BAILEY: Open Payments
NPI 1578213377 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,742 in 47 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,291 · 2025 $1,742
Food & beverage: $1,692Education: $50
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 9 | $346 |
| Kite Pharma, Inc. | 7 | $342 |
| BeOne Medicines USA, Inc. | 6 | $200 |
| ABBVIE INC. | 3 | $146 |
| Celgene Corporation | 4 | $126 |
| BeiGene USA, Inc. | 2 | $122 |
| E.R. Squibb & Sons, L.L.C. | 1 | $106 |
| KYOWA KIRIN, INC. | 4 | $98 |
| Novartis Pharmaceuticals Corporation | 2 | $58 |
| Genmab U.S., Inc. | 2 | $50 |
Products named: MONJUVI, BRUKINSA, BREYANZI, Yescarta, VENCLEXTA, POTELIGEO, Epkinly, LUTATHERA.
Industry payments across AL — which companies pay providers there.
